Jennifer R. Diamond, MD

Articles by Jennifer R. Diamond, MD

Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer

ByJennifer Weiss, MD,Anosheh Afghahi, MD,Elena Shagisultanova, MD, PhD,Jennifer R. Diamond, MD

October 17th 2018

An otherwise healthy 58-year-old woman with a history of breast cancer presents to the clinic with newly diagnosed metastatic disease; eventual abdominal CT showed a mass in the transverse colon with ascites and peritoneal nodularity. What is the best initial systemic treatment for her?

A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer

ByEricson Stoen, MD,Peter Kabos, MD,Kelly C. Borden, MD,Regina J. Brown, MD,Virginia F. Borges, MD, MMSc,Jennifer R. Diamond, MD

June 15th 2018

A 35-year-old woman noticed a mass in her right breast and underwent a diagnostic workup, including a mammogram that revealed a 2.4-cm mass and ultrasound that showed two adjacent masses, as well as enlarged axillary lymph nodes.

Early-Stage BRCA2-Linked Breast Cancer Diagnosed in the First Trimester of Pregnancy Associated With a Hypercoagulable State

ByJennifer R. Diamond, MD,Christina A. Finlayson, MD,Christiane Thienelt, MD,Peter Kabos, MD,Laura Hardesty, MD,Linda Barbour, MD, MSPH,Catherine E. Klein, MD,Rachel Rabinovitch, MD,Anthony D. Elias, MD,Virginia F. Borges, MD, MMSc

August 17th 2009

This feature examines the case of a patient with newly diagnosed breast cancer in the setting of a first-trimester pregnancy presenting to our multidisciplinary breast cancer clinic.